Testing tetanus antibodies in saliva
Part of Infections clinical trials.
This study checks if a simple saliva test can detect tetanus protection, which could replace blood tests. It includes healthy children, young adults, pregnant women, and adults with certain health conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to give consent, or have a parent/guardian do it for you.
- You are in one of these groups: healthy children aged 5-10, healthy adults aged 18-25, pregnant women at any stage, or adults aged 18-45 with a condition that might affect vaccine response.
- You must not have a bleeding disorder that makes blood sampling risky.
- For groups A, B, and C, you must not have any health condition that could affect your immune response or make blood sampling unsafe.
- You must be willing to follow study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
This study tests an injection that may help prevent tetanus in people who have had a high-risk exposure, like a deep or dirty wound. It aims to see if the injection is safe and effective for protecting against tetanus.
This study checks how long your body's protection from the tetanus vaccine lasts. It follows up with people who already got the vaccine in an earlier study to see if their immunity is still strong years later.
This study tests a new microneedle patch that delivers a tetanus booster vaccine through tiny needles in the skin, without a traditional shot. The patch is applied to the forearm, and the study checks its safety and how the body responds.
This study compares a new tetanus shot (siltartoxatug) with standard tetanus treatments to see if it works as well. It is for people aged 18 and older who need tetanus protection after an injury.
This trial tests a new combined vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and how well it works to boost immunity in teens and adults.
Hear when a new Tetanus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.